Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the SWEDEHEART Platform

NCT02311231 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT02311231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02311231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on the SWEDEHEART Platform
Lead sponsor
Uppsala University
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
March 31, 2017
Enrollment
6,012 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non st-segment elevation myocardial infarction, st-segment elevation myocardial infarction